Canine lymphoma (cL) is a common type of neoplasia in dogs with an estimated incidence
rate of 20–100 cases per 100,000 dogs and is in many respects comparable to non-Hodgkin …

Simple Summary Canine lymphoma is a common cancer of one of the white blood cells that
is commonly treated with chemotherapy. Many papers have been published about this …

Lymphoma (malignant lymphoma or lymphosarcoma) comprises a diverse group of
neoplasms that have in common their origin from lymphocytes. The neoplasms usually arise …

The purpose of all disease classification systems is to define disease entities based on their
biological behavior. In the process of defining criteria for various disease entities, we may err …

A paraneoplastic syndrome (PNS) is a neoplasmassociated alteration in bodily structure or
function that occurs distant to the tumor. PNSs are an extremely diverse group of clinical …

Standard of care treatment of dogs with multicentric lymphoma includes combination
chemotherapy with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP); …

The purpose of this study was to evaluate the efficacy and toxicity of an intensified dose
protocol with no maintenance phase for the treatment of canine lymphoma. Forty‐nine dogs …

Canine idiopathic thrombocytopenic purpura (ITP) is a disease in which antibodies bound to
the surface of platelets mediate premature platelet destruction by macrophages. ITP in dogs …

Paraneoplastic syndromes (PNSs) are neoplasm-associated alterations in bodily structure
or function or both that occur distant to the tumor. They are an extremely diverse group of …

Background: Hemangiosarcoma (HSA) is a highly metastatic and often rapidly fatal tumor of
dogs. At present, adjuvant chemotherapy is the only proven effective treatment for dogs with …